Literature DB >> 18923660

Metabolic syndrome and sleep apnea.

I Kostoglou-Athanassiou1, P Athanassiou.   

Abstract

Metabolic syndrome is a disorder characterized by abdominal obesity, hypertension, increased triglycerides, decreased HDL cholesterol and increased blood glucose. Accumulating evidence strongly indicates that insulin resistance and an increased amount of abdominal fat are the pathogenic factors for the characteristics of metabolic syndrome. The metabolic syndrome is characterized by an increased risk for the development of cardiovascular disease and type 2 diabetes mellitus. Studies indicate that sleep apnea may be a manifestation of the metabolic syndrome. It has also been suggested that the metabolic syndrome or "syndrome X" should also comprise obstructive sleep apnea and should then be called syndrome "Z". It appears that obstructive sleep apnea and the metabolic syndrome are characterized by the same pathophysiologic environment, which increases the risk for the development of cardiovascular disease. The increased amount of visceral fat and the accompanying insulin resistance seem to be the main characteristics responsible for the development of obstructive sleep apnea and the metabolic syndrome.

Entities:  

Keywords:  metabolic syndrome; obesity; obstructive sleep apnea; sleep apnea

Year:  2008        PMID: 18923660      PMCID: PMC2464309     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  65 in total

Review 1.  Interactions between obstructive sleep apnea and the metabolic syndrome.

Authors:  Anna Svatikova; Robert Wolk; Apoor S Gami; Michal Pohanka; Virend K Somers
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

Review 2.  Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.

Authors:  N Abate
Journal:  J Diabetes Complications       Date:  2000 May-Jun       Impact factor: 2.852

3.  Sleepiness-related accidents in sleep apnea patients.

Authors:  S Horstmann; C W Hess; C Bassetti; M Gugger; J Mathis
Journal:  Sleep       Date:  2000-05-01       Impact factor: 5.849

4.  Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; L Mykkänen; R P Tracy; D J Zaccaro; C N Hales; S M Haffner
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

5.  Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.

Authors:  E Ernst; K L Resch
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

6.  Relationship of metabolic syndrome and obstructive sleep apnea.

Authors:  James M Parish; Terrence Adam; Lynda Facchiano
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

7.  The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

Authors:  B J Potter van Loon; C Kluft; J K Radder; M A Blankenstein; A E Meinders
Journal:  Metabolism       Date:  1993-08       Impact factor: 8.694

8.  C-reactive protein is independently associated with fasting insulin in nondiabetic women.

Authors:  Aruna D Pradhan; Nancy R Cook; Julie E Buring; JoAnn E Manson; Paul M Ridker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-06       Impact factor: 8.311

9.  Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study.

Authors:  Olivier Milleron; Rémy Pillière; Arlette Foucher; Florence de Roquefeuil; Philippe Aegerter; Guillaume Jondeau; Bernadette G Raffestin; Olivier Dubourg
Journal:  Eur Heart J       Date:  2004-05       Impact factor: 29.983

Review 10.  Obesity, sleep apnea, and hypertension.

Authors:  Robert Wolk; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

View more
  5 in total

1.  APAP impact on metabolic syndrome in obstructive sleep apnea patients.

Authors:  Patrícia Caetano Mota; Marta Drummond; João Carlos Winck; Ana Cristina Santos; João Almeida; José Agostinho Marques
Journal:  Sleep Breath       Date:  2010-09-24       Impact factor: 2.816

2.  Association of glucose transporter 4 genetic polymorphisms with obstructive sleep apnea syndrome in Han Chinese general population: a cross-section study.

Authors:  Ting Yin; Nan Fang Li; Mulalibieke Heizhati; Juhong Zhang; Jingjing Zhang; Ling Zhou; Guijuan Chang
Journal:  Lipids Health Dis       Date:  2014-01-12       Impact factor: 3.876

Review 3.  Biological Potential of Polyphenols in the Context of Metabolic Syndrome: An Analysis of Studies on Animal Models.

Authors:  Joanna Niewiadomska; Aleksandra Gajek-Marecka; Jacek Gajek; Agnieszka Noszczyk-Nowak
Journal:  Biology (Basel)       Date:  2022-04-07

4.  Uncontrolled blood pressure and risk of sleep apnea among blacks: findings from the Metabolic Syndrome Outcome (MetSO) study.

Authors:  A Seixas; J Ravenell; N J Williams; S K Williams; F Zizi; G Ogedegbe; G Jean-Louis
Journal:  J Hum Hypertens       Date:  2015-08-06       Impact factor: 3.012

Review 5.  Correlation between metabolic syndrome and sleep apnea.

Authors:  Alejandro Castaneda; Edgar Jauregui-Maldonado; Iqbal Ratnani; Joseph Varon; Salim Surani
Journal:  World J Diabetes       Date:  2018-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.